These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 21742077)

  • 1. GEOGRAPHIC PATHOLOGY OF MYOCARDIAL INFARCTION.
    LEE KT; NAIL R; SHERMAN LA; MILANO M; DEDEN C; IMAI H; GOODALE F; NAM SC; SCOTT RF; SNELL ES; DAOUD AS; JARMOLYCH J; JAKOVIC L; FLORENTIN R
    Am J Cardiol; 1964 Jan; 13():30-40. PubMed ID: 14103185
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel Pharmacogenomics: Validation in a Population of South-Asian Ancestry.
    Kreutz RP
    JACC Adv; 2023 Sep; 2(7):100572. PubMed ID: 38939475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis.
    Bellemain-Appaix A; Kerneis M; O'Connor SA; Silvain J; Cucherat M; Beygui F; Barthélémy O; Collet JP; Jacq L; Bernasconi F; Montalescot G;
    BMJ; 2014 Oct; 349():g6269. PubMed ID: 25954988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.
    Choi CU; Rha SW; Oh DJ; Poddar KL; Na JO; Kim JW; Lim HE; Kim EJ; Park CG; Seo HS; Hong TJ; Park JS; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim HS; Kim CJ; Yoon JH; Ahn TH; Tahk SJ; Chung WS; Seung KB; Chae SC; Park SJ; Ahn YK; Jeong MH
    Am Heart J; 2011 Feb; 161(2):373-382.e1-3. PubMed ID: 21315222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kim JY; Jeong MH; Moon JH; Ahn YK; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae IH; Cho MC; Jang YS; Yoon JH; Seung KB; Park SJ;
    Am J Cardiol; 2012 Dec; 110(11):1598-606. PubMed ID: 22935526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
    Lin GM; Li YH
    Am J Cardiol; 2011 Feb; 107(4):641. PubMed ID: 21295179
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
    Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial.
    Ducci K; Grotti S; Falsini G; Angioli P; Liistro F; Mandò M; Porto I; Bolognese L
    Int J Cardiol; 2013 Oct; 168(5):4814-6. PubMed ID: 23916779
    [No Abstract]   [Full Text] [Related]  

  • 9. Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.
    Lin GM; Li YH; Chu KM; Han CL
    Am Heart J; 2011 Jul; 162(1):e17. PubMed ID: 21742077
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.
    Vlaar PJ; Svilaas T; Damman K; de Smet BJ; Tijssen JG; Hillege HL; Zijlstra F
    Circulation; 2008 Oct; 118(18):1828-36. PubMed ID: 18852370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Hamdalla H; Moliterno DJ
    Expert Opin Pharmacother; 2006 Aug; 7(12):1669-73. PubMed ID: 16872270
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.